Benzinga | Nov 12, 2020 08:05AM EST

Dare Bioscience Q3 EPS $(0.24) Misses $(0.17) Estimate

Dare Bioscience (NASDAQ:DARE) reported quarterly losses of $(0.24) per share which missed the analyst consensus estimate of $(0.17) by 41.18 percent. This is a 20 percent decrease over losses of $(0.20) per share from the same period last year.